Retrotope

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

4300 El Camino Real Ste 201, Los Altos, ...

Phone Number

(650) 437-0700

Website

www.retrotope.com

Revenue

$7.4 Million

Industry

Manufacturing Pharmaceuticals

About Retrotope

Retrotope Inc. is focused on developing proprietary therapeutics aimed at treating degenerative diseases by down-regulating lipid peroxidation (LPO) to protect against cellular degeneration. The company is pioneering first-in-class therapies for a range of conditions, including orphan neurodegenerative diseases and larger market degenerative conditions, where treatment options are limited. Their pipeline includes compounds targeting diseases such as Infantile Neuroaxonal Dystrophy, Friedreich's Ataxia, and Amyotrophic Lateral Sclerosis. Retrotope's intended clients include patients suffering from these debilitating conditions, as well as healthcare providers seeking innovative treatment solutions.Explore more
Retrotope's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Retrotope Org Chart

PhoneEmail
VG
United States flag for contact location.
Vidhya Gopalakrishn...

Chief Development Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Retrotope

Compare insights from companies similar to Retrotope, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Retrotope

$7.4M
11-50
Private
$37.4M
2006
VG
Vidhya GopalakrishnanChief Development Officer
TauRx Pharmaceuticals
$27.1M
51-200
Private
$408M
2002
CG
Chung GohCo-founder & Chief Operating Officer
Anivive Lifesciences
$12.2M
11-50
Private
$20.4M
2015
CD
Chad DoddChief Commercial Officer
Melior Discovery
$11.1M
11-50
Private
<$5M
2005
AR
Andrew ReaumePresident & CEO
Theranica
$5.2M
11-50
Private
$86M
2016
Tim McCarthy, Chief Executive Officer at Theranica
Tim McCarthyCEO
Humanetics Corp
<$5M
11-50
Private
<$5M
1988
Ronald Zenk, Chief Executive Officer & Member of The Board of Directors at Humanetics Corp
Ronald ZenkCEO & Member of The Board of Directors
Illustration of an envelope

Retrotope Tech Stack

A closer look at the technologies used by Retrotope

WordPress.org

By

Automattic
PHP

By

PHP
Barracuda Networks

By

Barracuda Networks
Microsoft 365

By

Microsoft
See more technologies

Top Manufacturing Companies

Top companies in Canada by revenue

ACIC
AgMedica Bioscience
BWXT Medical
Steri-Med Pharma
Dalton Pharma Services
View Full List

Top companies in Australia by revenue

Tissue Repair
Clarity Pharmaceuticals
Phebra
Key Pharmaceuticals
Althea
View Full List

Top companies in New Zealand by revenue

TRG Natural Pharmaceuticals
Glycosyn
Ora Pharm
Novo Nordisk Group of Companies
Hale Animal Health
View Full List
See more top companies

Frequently Asked Questions Regarding Retrotope

What is Retrotope's official website?
Retrotope's official website is www.retrotope.com What is Retrotope's Revenue?
Retrotope's revenue is $7.4 Million What is Retrotope's SIC code?
Retrotope's SIC: 28,283 What is Retrotope's NAICS code?
Retrotope's NAICS: 32,325 How many employees does Retrotope have?
Retrotope has 11-50 employees What industry does Retrotope belong to?
Retrotope is in the industry of: Manufacturing, Pharmaceuticals What is Retrotope competition?
Retrotope top competitors include: Humanetics Corp, Theranica, TauRx Pharmaceuticals, Melior Discovery What technology does Retrotope use?
Some of the popular technologies that Retrotope uses are: WordPress.org, PHP, Barracuda Networks, Microsoft 365 How do I contact Retrotope?
Retrotope contact info: Phone number: (650) 437-0700 Website: www.retrotope.com What does Retrotope do?

Retrotope Inc. is focused on developing proprietary therapeutics aimed at treating degenerative diseases by down-regulating lipid peroxidation (LPO) to protect against cellular degeneration. The company is pioneering first-in-class therapies for a range of conditions, including orphan neurodegenerative diseases and larger market degenerative condit... ions, where treatment options are limited. Their pipeline includes compounds targeting diseases such as Infantile Neuroaxonal Dystrophy, Friedreich's Ataxia, and Amyotrophic Lateral Sclerosis. Retrotope's intended clients include patients suffering from these debilitating conditions, as well as healthcare providers seeking innovative treatment solutions.Read More

 What are Retrotope social media links?
Retrotope Linkedin page Retrotope Twitter page Retrotope Facebook page Who invested in Retrotope?
Retrotope has 6 investors including PPP, Morningside Venture Investments, Mehta Family Partners and Timur Artemev. Is Retrotope a public company?
Retrotope is private company therefore does not currently have an official ticker symbol
See more information about Retrotope

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search